Rheumatoid Arthritis Clinical Trials in New York

Showing 161-180 of 1,972 trials

Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

NCT03636438

Determine the long-term safety of DTX301 following a single intravenous (IV) dose in adults with late-onset ornithine transcarbamylase (OTC) deficiency.

Ornithine Transcarbamylase (OTC) Deficiency

Ultragenyx Pharmaceutical Inc11 participantsStarted Aug 2018

Aurora, Colorado, United States • Boston, Massachusetts, United States • New York, New York, United States +6 more locations

TERMINATEDNA< 1 mile

Mitigation of Postoperative Delirium in High-Risk Patients

NCT05777187

Among patients with cognitive impairment (CI) that undergo surgery, the risk for developing postoperative delirium (POD) is high (50%) and associated with further morbidity and mortality. Yet, 30-40% of POD cases are preventable with perioperative management. This randomized pragmatic clinical trial aims to assess incidence of POD in adult surgical patients with CI, as well as provider adherence to a set of 12 perioperative best practice recommendations for perioperative management. Electronic health record (EHR) data will be used to identify patients as high risk for developing POD and clinical decision support (CDS) prompts within the EHR will display best practices. Cases will be randomized to either the control group, usual care or the intervention which includes the high-risk alert and best practice prompts.

Post-operative DeliriumDecision Support Systems, ClinicalCognitive Impairment

Icahn School of Medicine at Mount Sinai7,412 participantsStarted Jun 2023

New York, New York, United States

Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

Mitigation of Postoperative Delirium in High-Risk Patients

Rheumatoid Arthritis Trials in Other Cities

Product Surveillance Registry

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Eliminating Monitor Overuse Trial (EMO Trial)

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

PRP in ACLR to Prevent PTOA

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

DAY101 In Gliomas and Other Tumors

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

Other Conditions in New York